USD 3.60 Billion
Antimicrobial Susceptibility Testing Market Size, Share, Growth Analysis, By Test type(Phenotypic testing, genotypic testing, and rapid testing), By End user(Hospitals and diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies), By Product type(Instruments, reagents and kits, and software and services), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35B2120 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|Tables:
90
|Figures:
76
Antimicrobial Susceptibility Testing Market Insights
Global Antimicrobial Susceptibility Testing Market size was valued at USD 3.79 billion in 2022 and is poised to grow from USD 3.98 billion in 2023 to USD 5.69 billion by 2031, at a CAGR of 5.2% during the forecast period (2024-2031).
Antimicrobial susceptibility testing market is a crucial sector in the healthcare industry, essentially in infectious disease management and microbiology. The market is considerably driven by the rising cases of antibiotic-resistant bacteria that has remarkably increased the demand for AST or antimicrobial susceptibility testing for efficient treatment choices. Increasing prevalence of infectious diseases on the global scale is considerably driving the demand for reliable and accurate diagnostic technologies. Furthermore, growing advancements and innovations in diagnostic tools like automation in testing procedures and molecular methods are improving the precision and efficacy of antimicrobial susceptibility testing. The market is also positively impacted by the rising number of players, allowing providers to choose the suitable testing option.
Nonetheless, the global antimicrobial susceptibility testing market is anticipated to be hampered by the significant cost of AST technologies, lack of standardization, and growing complexity of procedures. The cost of AST technologies could create barriers to adoption, especially among the middle-income and low-income regions. This could restrict the broad adoption and hamper market growth. lack of standardized norms and procedures may result in variations in test outcomes, affecting reliability. Some of the AST techniques may be complex and demand specialized training. This could incur costs and be a barrier for a few healthcare settings. Yet, the market is opportune to factors like the growing trend of POC testing, offering prospects for user friendly AST solutions and improvements in regenerative medicine.
US Antimicrobial Susceptibility Testing Market is poised to grow at sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Phenotypic Testing
Fastest Growth
Rapid Testing
Growth Rate
5.20% CAGR
Global Antimicrobial Susceptibility Testing Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Antimicrobial Susceptibility Testing Market Segmental Analysis
Global Antimicrobial Susceptibility Testing Market is segmented on the basis of test type, end user, product type, and region. By test type, the market is segmented into phenotypic testing, genotypic testing, and rapid testing. By end user, the market is segmented into hospitals and diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies. By product type, the market is segmented into Instruments, reagents and kits, and software and services. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Antimicrobial Susceptibility Testing Market Analysis by Test Type
Based on test type, the antimicrobial susceptibility testing market is categorized into phenotypic testing, genotypic testing, and rapid testing. The phenotypic testing segment held a notable share of the market in the previous years and is expected to lead over the forecast period as well owing to established methodology, exhaustive results, and cost-effectiveness. Phenotypic testing types like broth microdilution and disk diffusion are well-developed and are prominently used in labs. Their reliability and history of use increases trust among clinicians. They offer direct evaluation of the response of microorganisms to antibiotics, providing useful insights in patterns of resistance and helping treatment decisions. Also, they are budget-friendlier than the novel molecular methods.
On the other hand, the rapid testing segment is projected to grow considerably over the forecast period owing to the result speed, improved patient outcomes, and rising demand for POC testing. Rapid tests offer results in just a few hours instead of days. This enables timely treatment and immediate clinical decision-making, which is needed in proper management of infections. The ability to swiftly detect appropriate anti-microbial therapy decreases the period of illnesses and reduces the complication risks. This results in enhanced patient outcomes. Furthermore, there is a rising trend towards POC testing, where these tests can be conducted in clinics. This increases convenience and accessibility for healthcare providers.
Antimicrobial Susceptibility Testing Market Analysis by End User
Based on end user, the market is segmented into hospitals and diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies. The hospitals and diagnostic laboratories segment held a notable market share in the previous years and is expected to continue dominance over the forecast period as well owing to higher patient volume, developed infrastructure, and clinical decision support. Hospitals manage many patient pools that drive the need for effective AST to guide decisions for treatment. Diagnostic labs and hospitals offer offers access to essential technology and professional staff to conduct several AST methods, comprising molecular and phenotypic tests. Hospitals also need accurate and speedy susceptibility testing for informed treatment, mainly in acute care settings.
On the other hand, the pharmaceutical and biotechnology companies' segment will hold a remarkable market share in the coming years owing to factors like drug development assistance, innovation and research, and collaborations and partnerships. These companies use AST to assess the efficiency of antimicrobial agents during drug development procedures. This confirms that the candidates are responsive to resistant strains. Also, there is an increased emphasis on R&D, leading to constant development of new testing techniques, impacting market growth. Moreover, several biotechnology and pharmaceutical companies are collaborating with diagnostic firms to improve their testing competencies and incorporate AST in their product lines.
Global Antimicrobial Susceptibility Testing Market Size By Test Type
To get detailed analysis on other segments, Request For Free Sample Report
Antimicrobial Susceptibility Testing Market Regional Insights
Geographically, North America dominated the market in the previous years and is expected to lead over the forecast period owing to the developed healthcare infrastructure, strong research and development, and rising cases of infectious diseases. The region holds high-tech healthcare systems with superior diagnostic facilities and laboratories, allowing widespread adoption of antimicrobial susceptibility testing. There is a robust investment in research and development from private and public firms that nurture advancements and innovations in AST methods and technologies. The region also faces a large population with infectious diseases, thus impacting regional growth. The key players profiled in the region include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Abbott Laboratories, Agilent Technologies, Inc., and more.
Asia-Pacific is the fastest-growing region in the global antimicrobial susceptibility testing market due to the increasing prevalence of infectious diseases, rising awareness of (AMR) Antimicrobial Resistance, and enhancing healthcare infrastructure. The region is witnessing the growing incidences of infectious diseases, rising the demand for efficient testing. Recognition and increased awareness of AMR concerns is triggering healthcare providers and governments to emphasize AST as a unit of public health strategies. Also, several nations of Asia-Pacific are focusing on investment in developing diagnostic capabilities and healthcare infrastructure, thus aiding the adoption of AST tools. The market is also fueled by speedy economic growth, resulting in more healthcare spending and investments in R&D.
Global Antimicrobial Susceptibility Testing Market Size By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Antimicrobial Susceptibility Testing Market Dynamics
Antimicrobial Susceptibility Testing Market Drivers
Rising Antimicrobial Resistance and Cases of Infectious Diseases
- The growth of AMR is a major threat to global health. Health organizations and authorities are focusing on the need for efficient AST to observe resistance patterns. This helps in the guidance of treatment decisions and encouraging the use of antibiotics. Also, growing cases of infectious diseases are supported by factors like travel, urbanization, and population growth that demand treatment and diagnosis. This drives the demand for effective and reliable AST.
Growing Awareness for Infection Control
- Rising awareness among patients and healthcare professionals regarding infection control methods is fueling the use of AST. Hospitals are emphasizing AST to decrease the cases of HAIs. Also, the growth of healthcare facilities, especially in the developing economies is supporting the demand for AST. Moreover, better access to diagnostic services and effective and timely treatment is also propelling the growth of the market.
Restraints
Low Awareness and Regulatory Challenges
- In a few regions, mainly middle-income and low-income nations, individuals lack awareness of the benefits of AST. Moreover, poor training for the laboratory staff on the recent testing methods may hamper effective adoption of AST. Also, the regulatory scenario for diagnostic instruments and solutions may be complicated and consume more time. Strict regulatory needs may delay the introduction of novel AST technologies in the market.
Growth of Alternate Testing Methods
- The emergence of competitive and alternate diagnostic techniques like NGS next-generation sequencing and rapid molecular tests may be a barrier for the traditional antimicrobial susceptibility testing techniques. These substitutes may offer faster results, leading to decreased demand for antimicrobial susceptibility testing. Furthermore, uncertainties regarding reimbursement for AST may hamper investment in improved technologies.
Request Free Customization of this report to help us to meet your business objectives.
Antimicrobial Susceptibility Testing Market Competitive Landscape
The competitive landscape of the global antimicrobial susceptibility testing market presents a combination of a plethora of market players, engaged in offering effective technologies and products. The leading market players like Becton, Dickinson and Company (BD), Thermo Fisher Scientific, Siemens Healthineers, and bioMérieux are focused on offering integrated solutions, innovative diagnostic technologies, and improved microbiology systems. Companies are also investing in R&D to develop improved testing methods and strategic alliances to expand market reach. Overall, the market is differentiated by collaborations, innovations, and focus on addressing the obstacles.
Antimicrobial Susceptibility Testing Market Top Player’s Company Profile
- Thermo Fisher Scientific Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Danaher Corporation (US)
- Becton, Dickinson and Company (US)
- bioMérieux SA (France)
- Roche Diagnostics (Switzerland)
- Abbott Laboratories (US)
- Bruker Corporation (US)
- Merck KGaA (Germany)
- Agilent Technologies, Inc. (US)
- ConvaTec Group plc (UK)
- Cepheid (US)
- HiMedia Laboratories Pvt. Ltd. (India)
- Liofilchem s.r.l. (Italy)
- Accelerate Diagnostics, Inc. (US)
- Creative Diagnostics (US)
- Bio-Rad Laboratories (US)
- Synbiosis (UK)
- ELITechGroup (France)
- QIAGEN N.V. (Germany)
Antimicrobial Susceptibility Testing Market Recent Developments
- In April 2024, Bio-Rad Laboratories, Inc. launched its primary ultrasensitive digital PCR assay (multiplexed), named ‘ddPLEX ESR1 Mutation Detection Kit’. This assay increased the company’s offering in the oncology segment, wherein multiplexed and sensitive mutation detection assays help therapy selection, translational research, and disease monitoring.
- In February 2024, Danaher Corporation launched a fresh strategic alliance with Cincinnati Children's Hospital Medical Center to improve safety for patients by resolving the major cause of let-down in clinical trials.
- In April 2022, Thermo Fisher Scientific Inc. showcased its exhaustive solutions to help laboratories in infectious disease testing, sepsis treatment and diagnosis, and ecological sustainability at 2022 ECCMID. The ultra-modern ‘Q-linea ASTar System for Rapid AST Testing’ system offers accurate minimum inhibitory concentration outcomes within 6 hours.
Antimicrobial Susceptibility Testing Key Market Trends
- Growing Adoption of Rapid Testing Techniques: There is a rising focus on rapid antimicrobial susceptibility testing that offers immediate results, mostly within a few hours instead of days. Methods like mass spectrometry, molecular diagnostics, and automated systems are currently being developed to accelerate the detection of pathogens and susceptibility profiles. This is especially useful in critical care settings, wherein prompt decisions are important, affecting patient outcomes.
- Standardization and Regulatory Efforts: As antimicrobial susceptibility testing is transforming, there is a greater demand for standardization and oversight of testing methods. Regulatory bodies are making efforts to impose clearer standards and guidelines to guarantee comparability and reliability of antimicrobial susceptibility testing results in diverse technologies and laboratories. This trend is vital for improving trust in antimicrobial susceptibility testing results and streamlining global initiatives to fight antimicrobial resistance.
Antimicrobial Susceptibility Testing Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the antimicrobial susceptibility testing market is considerably progressing due to emerging market opportunities in developing regions like Latin America and Asia-Pacific, the growing integration of POC testing, growth in research and development activities, and emphasis on personalized medicine. However, the market is hampered by the growth of new pathogens, limitations associated with infrastructure in the progressing markets, and variating healthcare budgets. North America is anticipated to lead the market due to increased education and growing awareness, strong research and development, and increasing incidences of infectious diseases. Nonetheless, a few opportunities for the growth of the antimicrobial susceptibility testing market include growing collaborations and partnerships, the growing integration of AST with personalized medicine, and the growing emphasis on rapid diagnostics techniques.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 3.79 billion |
| Market size value in 2031 | USD 5.69 billion |
| Growth Rate | 5.2% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Antimicrobial Susceptibility Testing Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Antimicrobial Susceptibility Testing Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Antimicrobial Susceptibility Testing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Antimicrobial Susceptibility Testing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Antimicrobial Susceptibility Testing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Antimicrobial Susceptibility Testing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
